Home / Health / Vision Loss Risk: GLP-1 Meds Under Scrutiny
Vision Loss Risk: GLP-1 Meds Under Scrutiny
24 Feb
Summary
- GLP-1 weight loss medications may increase macular degeneration risk.
- Smoking is a major risk factor for age-related macular degeneration.
- Healthy diet, exercise, and supplements can lower AMD risk.
Recent research indicates a potential link between GLP-1 weight loss medications and an increased risk of macular degeneration. This condition, affecting millions over 50, degrades central vision and has no cure, making early detection and prevention vital.
Ophthalmologists highlight that genetics and aging are primary risk factors for age-related macular degeneration (AMD). However, crucial lifestyle changes can significantly mitigate these risks. Quitting smoking, a major contributor to oxidative stress on retinal cells, is strongly advised to delay AMD progression and treatment resistance.
A balanced diet rich in leafy greens and adherence to the Mediterranean diet can support gut health, potentially reducing AMD's advancement. Specific supplements, such as the AREDS2 formula, have shown efficacy in slowing AMD progression in individuals with intermediate or late stages.
Furthermore, regular physical activity diminishes oxidative stress, benefiting overall well-being and potentially reducing the risk of advanced macular degeneration. Routine eye exams for individuals over 50 are essential for early detection, as symptoms often go unnoticed until later stages.
